Pre-existing and new-onset metabolic dysfunctions increase cirrhosis and its complication risks in chronic hepatitis B.

Shang-Chin Huang Tung-Hung Su Tai-Chung TsengSih-Han LiaoShih-Jer Hsu Chun-Ming Hong Ting-Yuan Lan Chen-Hua Liu Hung-Chih YangChun-Jen LiuJia-Horng Kao

Published in: The American journal of gastroenterology (2024)

Concurrent and new-onset MD increase the risks of cirrhosis and cirrhotic complications in CHB patients, independent of hepatic steatosis. Proactively investigating metabolic comorbidities in CHB is critical to stratify the risk of liver disease progression.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
human health
chronic kidney disease
hepatitis b virus
prognostic factors
risk factors
risk assessment
molecular dynamics
locally advanced
patient reported